Search Results - Bian, A.Rosa

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study

    Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study by Colozza, M, Bisagni, G, Mosconi, A.M, Gori, S, Boni, C, Sabbatini, R, Frassoldati, A, Passalacqua, R, Bian, A.Rosa, Rodinò, C, Rondini, E, Algeri, R, Di Sarra, S, De Angelis, V, Cocconi, G, Tonato, M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    C-ERB-B2 expression as a predictor of outcome in a randomized trial comparing adjuvant CMF vs single-agent epirubicin in stage I-II breast cancer (BC) patients

    C-ERB-B2 expression as a predictor of outcome in a randomized trial comparing adjuvant CMF vs single-agent epirubicin in stage I-II breast cancer (BC) patients by Colozza, M., Gori, S., Mosconi, A.M., Bucciarelli, E., Bisagni, G., Rodinò, C., Bian, A.Rosa, Sabbatini, R., Mazzocchi

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: